- Research article
- Open Access
Over expression of the selectable marker blasticidin S deaminase gene is toxic to human keratinocytes and murine BALB/MK cells
© Bento et al; licensee BioMed Central Ltd. 2004
- Received: 30 March 2004
- Accepted: 02 December 2004
- Published: 02 December 2004
The blasticidin S resistance gene (bsr) is a selectable marker used for gene transfer experiments. The bsr gene encodes for blasticidin S (BS) deaminase, which has a specific activity upon BS. Therefore, its expression is supposed to be harmless in cells. The work reported on herein consisted of experiments to verify a possible toxicity of bsr on mammalian cells, which include several cell lines and primary cultures.
Murine keratinocyte BALB/MK and human primary keratinocyte cells transduced with the retroviral vector LBmSN, which has an improved expression system of bsr, namely bsrm, died in five days after the transduction. Meanwhile the control vector LBSN, which expresses bsr, did not provoke cell death. The lethal activity of bsrm was observed only in human keratinocytes and BALB/MK cells among the cell types tested here. Death appears to be mediated by a factor, which is secreted by the BALB/MK transduced cells.
By our study we demonstrated that the expression of bsrm gene is toxic to human keratinocytes and BALB/MK cells. It is likely over expression of BS deaminase gene is responsible for the death.
- NIH3T3 Cell
- Human Keratinocytes
- Human Primary Keratinocytes
- Virus Produce Cell
- Human Colorectal Carcinoma Cell Line
Blasticidin S (BS) is a nucleoside antibiotic isolated from Streptomyces griseochromogenes, and has been used as a fungicide against rice blast disease . BS inhibits protein synthesis in both prokaryotes and eukaryotes . Later, a gene that provides resistance against BS (bsr) was isolated from Bacillus cereus K55-S1 strain [2, 3]. The bsr gene possesses only 420 bp  and codes for an enzyme of 15 kDa, which is usually present in its dimer form . The enzyme acts upon BS converting it into a deaminohydroxy derivative [5, 6], thus it is named BS deaminase.
BS antibiotic is highly toxic to mammalian cells; even 2 μg/ml is enough to kill HeLa cells in a few days. However, the cells transfected with bsr could resist against BS at several fold higher concentrations . Hence, the BS/bsr pair has been used as an efficient selection system for gene transfer experiments in many different cell types.
Recently, we reported that some modifications introduced into the non-coding regions of the bsr gene (bsrm) resulted in an increase (several fold) of bsr gene expression, and consequently, NIH3T3 cells transduced by retroviral vectors could be selected with higher concentrations of BS in just a few days . Even with such extensive use of the bsr/BS selection system, no side effects in response to bsr gene expression have been observed.
Using the murine keratinocyte cell line BALB/MK  and human primary keratinocytes, we report here a surprising death of the keratinocytes provoked by the expression of bsrm. A detailed investigation about the death of keratinocytes, which was mediated by an unknown molecule and secreted by the BALB/MK cells transduced with LBmSN, is discussed below.
Sensitivity of BALB/MK cells to BS
To determine the range of BS concentrations and the time required for BALB/MK cell death to occur, 1 × 104 cells/well were incubated in a 24 well plate and 2 days later the media were replaced with a fresh one containing various concentrations of BS for 9 days. A BS concentration of at least 2 μg/ml was necessary to kill the cells in 5 days. At concentrations of BS greater than 8 μg/ml the majority of cells died within 3 days.
Effect of bsrm gene and BS on BALB/MK cells
Removal of BS from the medium of the cells selected with 8 μg/ml BS resulted in cell death within a week (not shown). Thus, the BS antibiotic counteracted the death effect of bsrm and therefore has a vital role to BALB/MK cells transduced with LBmSN.
Effects of cell density and virus concentration upon induction of BALB/MK cell death
The effect of cell density on inducing death
Time till cell death1 (days)
1.0 × 103
5.0 × 103
1.0 × 104
1.5 × 104
2.0 × 104
4.0 × 104
Effect of the BALB/MK cells expressing bsrm upon BALB/MK cells
Effect of bsrm on mammalian cell lines
The lethal effect provoked by bsrm was firstly observed in the murine keratinocyte cell line BALB/MK as described above. To verify this lethal effect in other cell types, we chose the cells originated from the skin or epithelium (NIH3T3, HeLa, LISP-A10, LISP-E11, HCT-8 and B16F10), because of the origin of the BALB/MK cells . In addition, the rat vascular smooth muscle cells, which are useful for gene therapy experiments , were also tested.
Until 7 days post-infection none of the above cells, which were transduced with LBmSN retroviral vector, did not die, whereas the control cell line BALB/MK died 5 days after the transduction (not shown). As the viral transduction rate is essential to analyze the possible death effect by the expression of bsrm, the cells were transduced with a ten-fold higher number of viruses than cells. Even in such conditions no cell types suffered with the expression of bsrm.
To ensure the transduction and expression of bsrm in the cells, those transduced cells were selected with 8 μg/ml of BS from the non-transduced ones that die in 4 days. The selected cells were distributed to two plates, and in one plate the initial concentration of BS was maintained and in from the other plate the BS was removed. During the 7 days of observation no death was observed in both plates (not shown), which confirm the previous result that the bsrm gene is not lethal to those cell types.
Comparison of the vectors LBmSN and LBSN upon BALB/MK and NIH3T3 cells
Effect of the BS analogs on BALB/MK cells
The analogs of BS, cytidine, 5'-deoxycytidine, uridine and 5'-deoxyuridine, were tested in the culture of the BALB/MK cells transduced with LBmSN at 1 μM to 10 mM concentrations (Figure 4). Interestingly all analogs with 10 mM protected the transduced cells during 5 days of observation. Changing the medium with a fresh one containing 10 mM of each analog at every five days, the cells could be maintained alive for several passages (not shown).
Effect of the bsrm gene and BS upon human keratinocytes
The vector LBmSN also expresses neo R , which provides resistance against geneticin. However, the transduced keratinocytes died after the incubation with 500 μg/ml of geneticin (Figure 6) even if the antibiotic was neutralized by aminoglycoside phosphotransferase. This result corroborates previous data that in keratinocytes the expression of bsrm gene leads to cell death. The keratinocytes transduced with the LXSN vector , which was used to construct the LBmSN vector, presented normal growth reaching complete confluence within 8 days (not shown).
Here we report a surprising death caused by the transduction of the murine keratinocyte cell line BALB/MK cells with the retroviral vector LBmSN. This vector expresses bsrm which is a modified form of bsr only in the non-coding region; consequently both genes express the same BS deaminase. As the vector LBSN, which expresses bsr much lower than LBmSN , did not kill the cells an over expression of bsr could be responsible for the death. However, we can not discard other possibilities caused by interactions of the bsrm gene product (mRNA or protein) with intracellular molecules.
In some cases the Moloney murine retrovirus can cause cell death . However in our case the control retroviral vector LXSN, which was used to construct LBmSN and LBSN does not carry any viral genes , did not induce cell death in the same culture conditions (Figure 1). Additionally the wide range of viral concentrations and cell densities tested here (Table 1 and Figure 3) did not affect cell death. These last results corroborate the above conclusion that the death of BALB/MK cells was caused by the expression of bsrm.
An interesting phenomenon of the death of BALB/MK cells expressing bsrm was that those cells can be rescued if a lethal concentration of BS (8 μg/ml to 32 μg/ml of BS were tested) is added in the medium before three days after transduction. It was a paradox, since the toxic antibiotic, BS, was able to rescue the murine keratinocyte BALB/MK induced to die by the apparently inoffensive bacterial bsrm gene.
BS-rescuing process of the bsrm-transduced keratinocytes could be understood as a consequence of inhibition of the death factor (DOKEB) production by BS. Because those transduced keratinocytes could be maintained for long period (at least two months) simply by changing the medium every two days for a fresh one containing 8 μg/ml of BS (not shown). However, we do not know if the inhibition of DOKEB production is caused by the inhibition of protein synthesis by BS or just occupation of the active site of the BS deaminase by BS, and consequently inhibiting the binding of the first target molecule which is a responsible for the induction of the death process. We believe more in the last explanation, because if the analogs of BS were added to the medium at concentrations higher than 1 mM, cell death can be avoided (Figure 4). The requirement of higher concentration of the analogs of BS than BS, which requires only 19 μM to protect the bsrm expressing BALB/MK cells, is likely due to the low affinity of analogs for BS deaminase as expected .
Even though we have demonstrated that the expression of the bsrm gene in BALB/MK is lethal, the bsrm/BS selection system can still be used in keratinocytes. During the selection of LBmSN-transduced keratinocytes, the initial concentration of BS in the medium should determine a strict range of LBmSN transduced keratinocytes, which express not more and not less than certain levels of bsrm gene (Figure 6). Thus, for survival of those transduced cells AND selected with 8 μg/ml BS, the medium should be changed every 2 days to maintain active BS concentration in the medium; otherwise, the low BS concentration will allow the synthesis of DOKEB and in turn trigger the death mechanism. The BALB/MK cells transduced with LBmSN and selected with 8 μg/ml of BS should not be challenged with concentrations much higher than those used, since the cells expressing higher levels of bsrm gene should have died during the previous selection. Thus, the selected BALB/MK cells exist in a precarious situation where either apoptosis or necrosis can be easily activated at any unfavorable moment.
We evaluated if the lethal effect provoked by bsrm occurs exclusively in BALB/MK cells or if this phenomenon is general for all cell types. In this study we included normal human primary keratinocytes and several cell lines. The human keratinocytes are resistant to BS at concentrations lower than 2 μg/ml and at concentrations higher than 8 μg/ml the cells die within 5 days (not shown). However, the keratinocytes transduced with LBmSN behaved in an opposite way. In the absence or presence of BS at low concentrations (lower than 2 μg/ml) the transduced cells died, as it was observed with the BALB/MK cells transduced with LBmSN. Additionally, the protection against the death of the BALB/MK cells expressing bsrm by the addition of a lethal concentration of BS was also observed with the human keratinocytes expressing bsrm (Figs. 6, 7). These results indicate that the death process triggered by the expression of bsrm in keratinocytes should follow the same way.
Interestingly the lethal effect provoked by bsrm appears to be specific to keratinocytes, because none of the cell types tested here died in our experimental conditions, except for the human and murine keratinocytes. As the gene transfer and expression of bsrm are an essential step to access the lethal effect of bsrm, an alternative strategy used to verify the gene expression and its effect was selecting the transduced cells with 8 μg/ml BS and exposing the cells to a fresh medium without BS. Even in such conditions the bsrm gene did not cause any morphological alterations to those cell types, whereas the BALB/MK cells and the human primary keratinocytes transduced with LBmSN and selected with BS died in a few days after removal of the antibiotic (Figure 7). Therefore, we conclude that the lethal activity of bsrm is specific to those keratinocytes.
The analysis of DOKEB through exclusion molecular chromatography showed that the factor has a molecular weight equivalent of two amino acids (not shown). Therefore, DOKEB should not be BS deaminase, or even any protein. Further purification and molecular analysis are in progress.
In this study we demonstrated only in vitro that the expression of the reporter gene bsrm has a lethal effect on keratinocytes. However as most of the gene therapy experiments using keratinocytes are carried out ex vivo with retroviral vectors, our finding has a very important meaning. Because the cells transduced with retroviral vector carrying bsrm and selected with BS can survive until the antibiotic is maintained in the medium, but when those cells are returned to the own organism, which has no BS in it, DOKEB will be produced and can provoke serious lesion in the body.
By this study we also point out the danger of using heterologous genes, in particular those isolated from the microorganisms, in gene transfer and gene therapy experiments without proper controls.
We demonstrated in this study that the expression of the reporter gene bsrm has a lethal effect on the murine BALB/MK cell line and human primary keratinocytes. It is likely over expression of the BS deaminase gene is responsible for the death. The death appears to be mediated by a factor, which is secreted by the BALB/MK transduced cells. By this study we point out the danger of using heterologous genes, in particular those isolated from the microorganisms, in gene transfer experiments without proper controls.
The retroviral vectors used in the present study are based on the Moloney murine leukemia virus: LXSN , LBSN  and LBmSN . The letters L, X, S, N, B, Bm of those vectors represent retroviral LTR promoter, cloning site, promoter of simian virus SV40, neomycine resistance gene (neoR), bsr and bsrm, respectively. The LBSN and LBmSN vectors were constructed inserting the bsr and bsrm genes into the Hpa I site of LXSN, which is located in the cloning site .
Cell line culture
The amphotropic retrovirus producing cell clones PA317/LBmSN, PA317/LBSN and PA317/LXSN , the murine fibroblast NIH3T3, HeLa, the human colorectal carcinoma cell lines LISP-A10 and LISP-E11  were cultured in Dulbecco's modified Eagle medium (DMEM) with high glucose (4.5 g/ml), supplemented with 2 mM glutamine, 200 U/ml penicillin, 200 μg/ml streptomycin and 10 % fetal bovine serum (FBS) (InVitrogen, São Paulo, Brazil) at 37°C in a humidified atmosphere with 5 % CO2. The mouse fibroblast CCL-92 (ATCC) was cultured as above, except that the FBS was replaced with the bovine calf serum (InVitrogen, São Paulo, Brazil). For the culture of the murine keratinocyte BALB/MK cells (kindly provided by Dr Stuart A. Aaronson, The Derald H. Ruttenberg Cancer Center, New York, NY), EMEM (Biofluids, Rockville, MD) containing 0.05 mM CaCl2, 10 ng/ml of EGF and 10 % FBS was used.
The human colorectal carcinoma cell line HCT-8 and the murine melanoma cell line B16F10  were cultured in RPMI 1640 (InVitrogen, São Paulo, Brazil) supplemented with 0.2 % NaHCO3, HEPES 10 mM, pH 7.3, 40 μg/ml garamicine and 10 % FBS at 37°C in a humidified atmosphere with 5 % CO2.
Rat primary smooth muscle cell culture and viral transduction
A primary culture of rat smooth muscle cells was prepared as previously described , digesting the Wistar isogenic rat aortas enzymatically. These cells were characterized immunocytochemically using antibodies against α-actin (Boehringer Mannheim, São Paulo, Brazil) for SMC positive staining and von Willebrand factor (Boehringer Mannheim, São Paulo, Brazil) for SMC negative and endothelial cell positive staining . Only early-passage smooth muscle cells were exposed for 24 h to virus harvested from PA317/LBmSN cells for a period of 24 h in the presence of Polybrene (8 μg/ml, Sigma)
Transduction of mammalian cell lines with retroviral vectors
The target cells were seeded on a 24 well plate at 1 × 104 cells per well with an appropriate medium as mentioned above. In parallel, 1 × 106 of virus producing cells (PA317/LBmSN, PA317/LBSN or PA317/LXSN) were seeded in a 25 cm2 flask. After 24 h, the media from the target cells and the virus producing cells were replaced with a fresh one used for target cells. On the next day, the media of the target cells were replaced with 500 μl of the virus solution collected from the supernatant of the PA317/LBmSN cell culture and filtered in 0.45 μm syringe filter. Polybrene was added to the virus solution at the final concentration of 8 μg/ml. One day after the infection, the media were replaced with a fresh one, maintained in the CO2 incubator and the cells were observed using a microscope everyday.
In parallel, after two days of the infection, a new set of the transduced cells was split and only 1/10 part of the cells was maintained in the same well. The BS antibiotic was added to the wells at concentrations between 0 to 32 μg/ml. When the cells reached confluence they were split and transferred to two wells of a 12-well plate. To one well, BS was added at the concentration used for selection, and another well was maintained without BS. The cells were observed under the microscope everyday.
Human primary keratinocytes culture and viral transduction
Normal human keratinocytes from healthy adult volunteers were obtained by biopsy, cut in small pieces and incubated in a trypsin solution (0.05 %) containing 0.01 % EDTA at 37°C for 3 h under constant agitation. Every 30 min the detached cells were transferred to a new 75 cm2 flask containing 2 × 106 cells of the irradiated CCL-92 cells (60 Gy) as a feeder-layer. The medium used for the culture of the keratinocytes was composed of DMEM and Ham's F12 (2:1) containing 10 % FBS, 4 mM glutamine, 50 IU/ml streptomycin- penicillin, 0.18 mM adenine, 5 μg/ml insulin, 5 μg/ml transferrin, 0.4 μg/ml hydrocortisone, 0.1 nM choleric toxin and 20 pM triiodotyronin . The medium was replaced every 2 to 3 days with a fresh one containing 10 ng/ml EGF. The cells were maintained in a humidified atmosphere with 5 % CO2.
For retroviral transduction, the packaging clones PA317/LBmSN and PA317/LXSN were irradiated with 30 Gy and used as a feeder-layer for the prepared previously keratinocyte cultures.
This study (00/14639-3) was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) in Brazil and FM Bento, CB Sacramento and Machado TR were recipients of FAPESP fellowships (98/02006-4, 01/09774-1 and 02/02032-2) and D Takeshita of CNPq.
- Takeuchi S, Hirayama K, Ueda K, Sakai H, Yonehara H: Blasticidin S, a new antibiotic. J Antibiot (Tokyo). 1958, 11: 1-5.Google Scholar
- Kamakura T, Kobayashi K, Tanaka T, Yamaguchi I, Endo T: Cloning and expression of a new structural gene for Blasticidn S deaminase, a nucleoside aminohydrolase. Agric Biol Chem. 1987, 51: 3165-3168.View ArticleGoogle Scholar
- Endo T, Kobayashi K, Nakayama N, Tanaka T, Kamakura T, Yamaguchi I: Inactivation of blasticidin S by Bacillus cereus. II. Isolation and characterization of a plasmid, pBSR8, from Bacillus cereus. J Antibiot (Tokyo). 1988, 41: 271-273.View ArticleGoogle Scholar
- Kobayashi K, Kamakura T, Tanaka T, Yamaguchi I, Endo T: Nucleotide sequence of the bsr gene and N-terminal amino acid sequence of blasticidin S deaminase from blasticidin S resistant Escherichia coli TK121. Agric Biol Chem. 1991, 55: 3155-3157.View ArticleGoogle Scholar
- Nawa K, Tamura Y, Sato K, Hattori J, Shimotohno KW, Endo T: Inactivation of blasticidin S by Bacillus cereus. V. Purification and characterization of blasticidin S-deaminase mediated by a plasmid from blasticidin S resistant Bacillus cereus K55-S1. Biol Pharm Bull. 1995, 18: 350-354.View ArticleGoogle Scholar
- Yamaguchi I, Seto H, Misato T: Substrate binding by blasticidin S deaminase, an aminohydrolase for novel 4-aminopyrimdine nucleosides. Pest Biochem Physiol. 1986, 25: 54-62. 10.1016/0048-3575(86)90031-3.View ArticleGoogle Scholar
- Izumi M, Miyazawa H, Kamakura T, Yamaguchi I, Endo T, Hanaoka F: Blasticidin S-resistance gene (bsr): a novel selectable marker for mammalian cells. Exp Cell Res. 1991, 197: 229-233. 10.1016/0014-4827(91)90427-V.View ArticleGoogle Scholar
- Freitas AC, Bento FM, Ramesh N, Osborne WR, Han SW: Modified blasticidin S resistance gene (bsrm) as a selectable marker for construction of retroviral vectors. J Biotechnol. 2002, 95: 57-62. 10.1016/S0168-1656(01)00442-4.View ArticleGoogle Scholar
- Weissman B, Aaronson SA: Members of the src and ras oncogene families supplant the epidermal growth factor requirement of BALB/MK-2 keratinocytes and induce distinct alterations in their terminal differentiation program. Mol Cell Biol. 1985, 5: 3386-3396.View ArticleGoogle Scholar
- Miller AD, Rosman GJ: Improved retroviral vectors for gene transfer and expression. Biotechniques. 1989, 7: 980-6, 989.Google Scholar
- Green H, Kehinde O, Thomas J: Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci U S A. 1979, 76: 5665-5668.View ArticleGoogle Scholar
- Beltrao-Braga PC, Koh IH, Silva MR, Gutierrez PS, Han SW: Vascular adventitia is a suitable compartment to transplant transduced vascular smooth muscle cells for ex vivo gene expression. Cell Transplant. 2002, 11: 583-592.Google Scholar
- Kim HT, Tasca S, Qiang W, Wong PK, Stoica G: Induction of p53 accumulation by Moloney murine leukemia virus-ts1 infection in astrocytes via activation of extracellular signal-regulated kinases 1/2. Lab Invest. 2002, 82: 693-702.View ArticleGoogle Scholar
- Solimene AC, Carneiro CR, Melati I, Lopes JD: Functional differences between two morphologically distinct cell subpopulations within a human colorectal carcinoma cell line. Braz J Med Biol Res. 2001, 34: 653-661.View ArticleGoogle Scholar
- Fidler IJ: Activation in vitro of mouse macrophages by syngeneic, allogeneic, or xenogeneic lymphocyte supernatants. J Natl Cancer Inst. 1975, 55: 1159-1163.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.